There are not two sides to the truth. One side is
Post# of 148180
It is dangerous thinking to say that there are always two sides. How about this one?
1) Leronlimab showed efficacy in a subset of critically ill people in the clinical trial, but they only got 2 doses because the FDA wouldn't let them do the 4-dose regimen. Therefore continuing with clinical trials, with the knowledge gained from this trial, and using the 4-dose regimen, is warranted.
2) The FDA says Leronlimab failed all its endpoints, therefore it is garbage that should be abandoned.
Do those "two sides" have equal validity?